BioNexus Gene Lab (BGLC) Operating Income (2018 - 2026)
BioNexus Gene Lab recorded quarterly Operating Income of -$540490.0 in Q1 2026, up 47.67% quarter-over-quarter from -$1.0 million in Q4 2025, and up 12.6% year-over-year from -$480003.8 in Q1 2025.
BioNexus Gene Lab's Operating Income history runs 9 years deep, the most recent figure standing at -$540490.0 for Q1 2026.
- In Q1 2026, Operating Income rose 12.6% year-over-year to -$540490.0; the TTM figure through Mar 2026 stood at -$2.9 million (down 36.63% YoY), while the FY2025 annual figure was -$3.0 million, down 88.41% from the prior year.
- Operating Income came in at -$540490.0 for Q1 2026 at BioNexus Gene Lab, up from -$1.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $259168.0 in Q2 2024 to a low of -$2.5 million in Q3 2023.
- A 5-year average of -$468471.9 and a median of -$272199.0 in 2023 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 310.09% in 2023 and fell as far as 3777.19% in 2023.
- BioNexus Gene Lab's Operating Income stood at -$122689.0 in 2022, then surged by 310.09% to $257754.0 in 2023, then sank by 261.48% to -$416220.0 in 2024, then tumbled by 148.15% to -$1.0 million in 2025, then jumped by 47.67% to -$540490.0 in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$540490.0, -$1.0 million, and -$702509.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 2.44 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 827.50 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 810.90 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 712.00 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 752.70 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 552.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 239.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 300.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -540,490.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -540,490.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -702,509.00 |
| Jun 30, 2025 | -611,293.00 |
| Mar 31, 2025 | -618,418.00 |
| Dec 31, 2024 | -416,220.00 |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 259,168.00 |
| Mar 31, 2024 | -79,028.00 |
| Dec 31, 2023 | 257,754.00 |
| Sep 30, 2023 | -2.53 Mn |
| Jun 30, 2023 | -272,199.00 |
| Mar 31, 2023 | -50,631.00 |
| Dec 31, 2022 | -122,689.00 |
| Sep 30, 2022 | -65,215.00 |
| Jun 30, 2022 | -137,964.00 |
| Mar 31, 2022 | 34,691.00 |
| Dec 31, 2021 | 201,063.00 |
| Sep 30, 2021 | 372,641.00 |
| Jun 30, 2021 | 139,990.00 |
| Mar 31, 2021 | 342,102.00 |
| Dec 31, 2020 | -3,040.00 |
| Sep 30, 2020 | 237,306.00 |
| Jun 30, 2020 | -33,974.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | -96,145.00 |
| Sep 30, 2019 | -50,138.00 |
| Jun 30, 2019 | -69,219.00 |
| Mar 31, 2019 | -60,203.00 |
| Dec 31, 2018 | -63,346.00 |
| Sep 30, 2018 | -55,142.00 |
| Mar 31, 2018 | 24,058.00 |